Waters Corporation WAT

NYSE · Healthcare · Medical - Diagnostics & Research

$440.45

Close on Fri, 20 Nov 2026 · market value $43.3B

What the price is betting on

Priced for a lot to go right

At $440, the price assumes revenue grows about 67% a year for three years, from $5.6B to about $18.4B by FY2028. That is about five times what analysts expect and about three times the company's own last three years.

The price assumes67%
Analysts expect13%
Last 3 years26%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.5% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than WAT? Check up to 5 of your stocks at once, free, no account.

0$5B$10B$15B$20B$5.6B'22'23'24'25Oct '26'26'27'28What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$61

Base

$72

Bull

$120

Today $440

  • Bear $61. The business grows 8% a year on average for only 1 year, then slows down.
  • Base $72. The business grows 13% a year on average over the 3 years analysts forecast, shaped like their forecast, then slows over 10 years, starting from 7%.
  • Bull $120. The business grows 18% a year on average for 5 years, longer than analysts forecast, then slows down.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$6.5B$6.5B, on the path
  3. FY2027$11.6B$7.2B, below the path
  4. FY2028$18.4B$7.6B, below the path

Each year's revenue at 67% growth from $5.6B in the 12 months to October 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NYSE

Revenue, FY2025
$3.2B
Growth, 3 years a year
26%
Cash margin
17%
Net debt
$903M
Shares, 3-year change
−1%
Dividend yield
0%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.